Review of the current approaches to the assessment of the drug innovative potential worldwide
A set of criteria for assessing the innovative potential of drugs (therapeutic value) have been developed and are widely used elsewhere. These approaches allow the state (the payer) to assess the clinical significance of a new medical product and make an educated decision on the reimbursement, cost...
Saved in:
Main Authors: | N. Z. Musina (Author), V. K. Fedyaeva (Author), V. V. Omel'yanovskii (Author), G. R. Khachatryan (Author), K. V. Gerasimova (Author), V. A. Lemeshko (Author), K. P. Konchits (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET
by: V. A. Lemeshko, et al.
Published: (2018) -
THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS
by: V. K. Fedyaeva, et al.
Published: (2017) -
NEW PHARMACEUTICALS. HOW CAN INNOVATIVENESS?
by: V.V. Omel'yanovskii, et al.
Published: (2011) -
NEW PHARMACEUTICALS. HOW CAN INNOVATIVENESS?
by: V.V. Omel'yanovskii, et al.
Published: (2011) -
The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia
by: V. V. Omelyanovsky, et al.
Published: (2018)